ABOUT THIS EPISODE
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Martin McLaughlin, former Head of Launch and Business Excellence at Takeda, to share the frameworks and lessons that help pharma organizations align people, processes, performance, and technology for success.
What You’ll Learn:
- How to break down the launch silo mentality plaguing 77% of pharma organizations
- Martin’s four-pillar launch playbook
- Why Launch Performance Indicators (LPIs) matter more than traditional KPIs
- How to operationalize scenario planning and pivot without losing momentum
- Where the real pharma AI wins actually happen
Martin McLaughlin is the former Head of Launch and Business Excellence at Takeda, bringing 25 years of industry experience spanning clinical development, sales, marketing, and launch strategy. With a background in science and industrial microbiology, he has built and led high-performing cross-functional teams through complex product launches across multiple therapeutic areas, including rare disease and competitive markets. Currently, Martin is Chief of Staff and Head of Commercial Excellence at Teva Pharmaceuticals.
Episode Highlights
- [00:00] Introduction
- [01:30] The Journey to Launch Excellence
- [04:02] The Four-Pillar Playbook
- [06:03] Building True Cross-Functional Teams
- [07:22] Launch Performance Indicators (LPIs)
- [08:46] The Six-Month Window That Defines Success
- [10:17] When the Market Fights Back
- [12:38] Institutional Memory for Global Teams
- [16:37] Where Tech Fits in Pharma Launches
- [20:02] Change Management and Building Capacity
- [25:00] Leading with Trust and EQ
- [26:06] Final Advice for Pharma Leaders
Episode Resources:
- Martin McLaughlin on LinkedIn
- Teva Pharmaceuticals Website
- Takeda Website
- Jonathan Kaskey on LinkedIn
- XSUNT Corporation Website
Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com
www.pharmasessions.substack.com
Pharma Sessions is handcrafted by our friends over at: fame.so
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OTHER EPISODES IN THIS PODCAST
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sonia Talwar, Senior Director of Scientific Communications and Medical Information in Hematology/Oncology at Pharmacosmos Therapeutics, to discuss how medical affairs can evolve from a reactive support function into a true strate…
Here’s what keeps pharma leaders awake at night: 70% to 80% of ChatGPT usage is healthcare-related/ However, most pharmaceutical organizations still treat AI as a future consideration rather than an immediate competitive necessity.
In this episode of Pharma Sessions, host Jonathan Kaskey is j…
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. David Shulkin, President of Shulkin Solutions, to discuss what it actually takes to lead through a healthcare crisis at scale. Dr. Shulkin shares insights about the current state of U.S. public health, the intersection of pol…
In this episode of Pharma Sessions, host Jonathan Kaskey sits down for a second time with Dr. David Shulkin, President of Shulkin Solutions, to challenge the pharmaceutical industry’s fundamental approach to drug pricing and argue that outcomes-based contracting is the path forward for sustainable …
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Eytan Abraham, the Chief Commercial and Technology Officer at Minaris Advanced Therapies, to dive into how pharma companies can choose the right CDMO partners, the future of cell and gene therapy manufacturing, and the hard-earne…
Disclaimer: The podcast and artwork embedded on this page are from Jonathan Kaskey, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
